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SESSION 1
THE MATERNAL AND FETAL POLYMORPHONUCLEAR CELL
CONTRIBUTIONS IN THE PLACENTA AND UMBILICAL CORD OF
PATIENTS WITH CLINICAL CHORIOAMNIONITIS AND PRETERM
DELIVERY. M. McNamara. D.O,, T Wallis, B.S., S Jacques, M.D., F
Qureshi, M.D., B Gonik, M.D. Depts. of Obstetric and Gynecology and
Pathology, Hutzel Hosp, Wayne State University, Detroit, MI.
Objective: To describe the maternal and fetal polymorphonuclear cell
(PMN) contributions in the umbilical cord and placenta in preterm
deliveries complicated by clinical chorioamnionitis.
Study Design: Five cases of preterm deliveries complicated by clinical
chorioamnionitis were retrospectively identified. Histologically severe
chorioamnionitis and funisistis were confirmed by hematoxylin and eosin
staining. Only male fetuses were studied. Thick sections of tissue were
obtained from representative paraffin tissue blocks. Cell suspensions
were obtained and cytospin slides were generated. The slides were then
prepared for X and Y chromosome probe labeling and fluorescent in-situ
hybridization (FISH). One hundred polymorphonuclear cells were
identified morphologically and the presence of two XX signals or a single
X and Y pair were noted under fluorescent microscopy. The ratio of
maternal to fetal PMNs were noted and compared from the placenta and
the umbilical cord.
Results: Maternal cells accounted for a mean of 86.4% of the total
PMNs identified in the placenta. Fetal PMNs accounted for a mean of
99.8% of the PMNs seen in the umbilical cord specimens.
Conclusion: In preterm clinical chorioamnionitis, the PMN response
observed in the placental mass is predominantly maternal. Conversely,
the accompanying funisitis seen on histologic examination is
predominantly fetal in origin.
INTERLEUKIN 1-[3, TUMOR NECROSIS FACTOR- OR LIPOPOLYSACCHARIDE
DOES NOT INDUCE APOPTOSIS OF AMNION CELLS IN VITRO. B.T. Oshtro, R. M.
Silver, S.S. Edwin, M. Monga, K. Ward. Depts. of Obstetrics and Gynecology and Human
Genetics, Universtty of Utah, Salt Lake City, UT and Dept. of Obstetrics and Gynecology and
Reproductwe Sciences, UT-HSC, Houston, TX.
Objective: Tumor necrosis factor-a (TNF) and other inflammatory mediators increased in the
gestational tissues of with infection related premature rupture of membranes (PROM) and
preterm labor. Also, apoptosis has been reported in fetal membranes taken from pregnancies
comphcated by PROM and has been proposed mechanism of membrane rupture. Since TNF
reduce apoptosts cell hnes, postulated that intrauterine mfecuon apoptosis
cells, leading PROM. The ob.lectwe of this study determine whether TNF,
mterleukm 1-[3 (IL-I), hpopolysacchandes (LPS) reduce apoptoss of cells in culture.
Study Design: We obtained fresh placental spectmens from pauents undergoing electtve repeat
Amnion cells solated and cultured Ham’s Fl2-Dulbecco’s modtfied
Eagle media supplemented wuh 10% fetal calf in 24-well tissue culture plates until
confluence. Apoptoss determined by DNA fragmentation assay. The cells incubated
with uCt trmated thymdtne for 18 hours, washed and then Incubated with medium for hours.
Cells further incubated quadruphcate fresh medium with various concentrations of TNF,
IL-I. E. coh derived LPS, for 24 hours. The cells then lysed and the radioactivity
determined by hqutd scmtillauon counung. Percent specific lragmcntation calculated expressed
relative control
Results: We Iound the apoptoss associated wth DNA fragmentation
ccll treated with IL-I, TNF LPS
IL-I TNF LPS
(% Control) (% Control) % Control)
0. ng/ml 99.7 99.9 100
10 ng/ml 100 99.9 100
100 ng/ml 99 99.8 99.4
Conclusion: IL-I, TNF, and LPS do induce apoptons amnion cells culture the
concentrations tested. Cytokine-induced apoptoss does appear be mechamsm for PROM.
AMNIOTIC FLUID DEFENSh-N LEVELS ARE ELEVATED EN" PRETE1L’vI LABOR
PATIENTS WITH SUBCLENICAL ENTRA-AMNIOTIC ENFECTION.
Heine. M.D., Kim Heller, M.D., Leo Mortimer, M.S., Phillip Grieg, M.D.*
University of Pittsburgh, Magee-Womens Hospital, Department of Obstetrics,
Gynecology and Reproductive Sciences, Pittsburgh, PA. "Greenville Hospital
System, Maternal Fetal Medicine Division, Greenville, SC.
OBJECTIVE: Defensins are neutrophil granule proteins released from activated
neutrophils in the setting of infection. The purpose of this study was to determine if
amniotic fluid defensin levels are elevated in preterm labor patients with subclinical
intra-amniodc infection. STUDY DESIGN: Amniodc fluid samples were obtained
from 186 pregnant patients with the
foIlowng clinical characteristics: 1500
Group term, no labor (N=50).
Group preterm, no labor (N=Sl).
Group 3, preterm labor with intra-
amntotic infecuon (N=20). Group 4,
preterm labor without intra-amniottc 1000
infecuo.n (N=35). Defensin levels
were measured by ELISA. Patient
groups were compared utilizing the
blann-Whitnev U test.
RESULTS: .k,iedian amniotic 500 tqutd defensin levels for the var3.’ing
patxent groups are presented in the
table. Patients with intra-amniotic
infection had significant increase
in ammotic fluid defensins when
compared to the other groups (p < .0001).
An amniotic fluid defensin level of > 400
ng/ml was highly suggestive of infection Group
wtth sensitivity, of 85% and specificity
ot’97%. CONCLUSION: Amniotic fluid defensin levels are elevated in patients with
PTL and subclinical intra-amniotic infection. Amniotic fluid defensin levels may be a
useful clinical tool for selecting preterm labor patients who might benefit from
antimicrobial therapy, closer observation, or earlv delivery.
ASSOCIATION BETWEEN EASILY OBSERVED MEMBRANE ROLL
CHARACTERISTICS AND HIGH AMNIOTIC FLUID INTERLEUKIN-6
LEVELS AMONG PATIENTS DELIVERING PREMATURELY
DL Patton, JE Hitti, MJ Krohn, SL Hillier, DA Eschenbach, Department of
Obstetrics and Gynecology and Medicine, University of Washington, Seattle, and
Department of Obstetrics and Gynecology, University of Pittsburgh, Pittsburgh.
INTRODUCTION: Amniotic fluid infection (AFI) and elevated cytokine levels
have been associated with prematurity. However, amniocentesis is not routinely
performed in the assessment of patients in preterm labor.
OBJECTIVE: To determine whether easily observed characteristics of membrane
rolls are associated with increased amniotic fluid (AF) levels of interleukin-6 (IL-
6) and AFI among patients delivering at <34 weeks.
STUDY DESIGN: The study population consisted of 102 women who presented
in preterm labor with intact membranes and delivered at <34 weeks gestation. AF
was collected by amniocentesis for culture and IL-6 enzyme immunoassay.
Formalin fixed, paraffin embedded, membrane rolls were assessed by light
microscopy for the presence of any inflammation, chorioamnion sloughing, and
necrosis. Logistic regression was used to calculate adjusted OR for the
associations between membrane characteristics and an elevated level of IL-6 or
positive culture.
RESULTS: Inflammation, sloughing and necrosis were positively associated with
elevated IL-6 levels
Membrane Roll IL-6 > 2000 pg/ml IL-6 .._.<.2000 pg/ml Adjusted 95% CI
Characteristic (n 37) (n 65) OR*
Inflammation 33/36 (92%) 31/63 (49%) 7.6 1.8-29.7
Sloughing 12/37 (32%) 14/65 (22%) 3.2 1.1-9.9
Necrosis 13/37 (35%) 4/65 (6%) 5.2 1.2-23.2
*Adjusted for other factors in tables and gestational age at delivery.
In similar logistic model, inflammation was also positively associated with AFI
(adjusted OR 9.1, 95% CI 1.1-73.7).
CONCLUSION: Easily observed membrane roll characteristics are positively
associated with elevated levels of AF IL-6 and AFI. In cases of preterm delivery,
light microscopic evaluation of the membrane roll is simple and inexpensive
method for estimating whether AFI has occurred, and may be of prognostic value
to the clinician.
BROAD-SPECTRUM BACTERIAL RIBOSOMAL RNA POLYMERASE CHAIN REACTION
FOR THE DETECTION OF AMNIOTIC FLUID INFECTION AMONG WOMEN IN PRETERM
LABOR. I-liffi, D Riley, MA Krohn, SL Hillier, K Agnew, Krieger, DA Eschenbach;
Departments of Obstetrics/Gynecology and Urology, Umversity of Washington.
OBJECTIVE: To determine the rate of amniotic fluid (AF) infection in preterm labor patients
with negative AF cultures, using bacterial ribosomal RNA polymerase chain reaction (rRNA
PCR).
STUDY DESIGN: 70 preterm labor patients with intact membranes at 22-34 weeks gestation
had AF collected by amniocentesis for culture and interleuktn-6 0L-6) enzyme
immunoassay. AF bacterial rRNA PCR for 17 patients with positive cultures were compared
with 14 patients with negative cultures and IL-6>2000 pg/ml and 39 patients with negative
cultures and low AF IL-6. Kruskal-Wallis ANOVA and paired Mann-Whitney tests with
Bonferroni correction were used to examine dfferences between +culture, -culture/+PCR,
and -culture/-PCR groups.
RESULTS: Bacterial rRNA PCR was positive in 15(88%) of 17 patients with positive cultures,
5(36%) of 14 patients with negative cultures and high IL-6, and 1(3%) of 39 patients with
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negative cultures and low IL-6 (p<O.OOOOl,x.2). Median (95%CI) cytok=ne levels, days to
delivery and birthweights are summarized:
+AF Culture (N=17) -Culture/+PCR (N=6) -Culture/-PCR (N=47)
Median (95% Cl) Median (95% el) Median (95% el)
L-6 (pg/ml) 25,800 (5,966-46,400) 11,958 (470-49,800) 190 (<70-267)*
TNF-(pg/ml) 876 (119-1101) 548 (<6-7249) <6 (<6)*
Days to Delivery (1-2) 1.5 (1-3) 19 (13-25)*
Birthweight(g) 900 (780-1542) 1679 (662-2307) 2695 (2362-2864)*
*Kruskal-Wallis ANOVA p<0.0001; paired Mann-Whitney <0.05 for difference between
culture/+PCR and -culture/-PCR groups.
CONCLUSIONS: PCR detects AF bacteria in 36% of patients with negative cultures and IL-6
levels 2000 pg/ml. Cytokine levels and pregnancy outcomes are similar in the +culture and
-culture/+PCR groups. The association between AF infection and preterm labor may be
underestimated by AF culture.
RESULTS: Twenty-one of 385 women (5.4%) were found to have ASB.
Performance of the screening tests ,are presented in the table below.
Technique Sensitivity Specificity PPV NPV
ATP 95 50 l0 99
LE 2 77 10 96
N 61 88 23 98
LE or N 76 69 12 98
CONCLUSION: ATP bioluminescence is an effective screening test for ASB
in pregnancy. Implementation of ATP testing prior to culture, thereby selecting women
with the greatest likelihood of ASB, would result in 50% reduction in urine cultures.
Future work will focus on optimizing differential cell lysis in order to improve
specificities and further reduce the need for routine culture.
METRONIDAZOLE TREATMENT OF BACTERIAL VAGINOSlS IN PREGNANCY,
AND PRETERM BIRTH: A RANDOMIZED, PLACEBO-CONTROLLED TRIAL.
HM McDonald Phi), JA O’Loughlin FRACOG, R Vigneswaran FRACP, PJ McDonald
FRACP, PT Jolley B Pharm, I.-Iarvey FRACOG, A Bof MBBS, Women’s & Children’s
Hospital, aThe Queen Ehzabeth Hospital, 3Lyell MeEwin Health Service, Adelaide, Austraha.
Objectives" To determine whether metronidazole treatment of bacterial vaginosis(BV) in
pregnancy reduces the rate of spontaneous preterm birth (PTB).
Study Design Randomised, double-blind, placebo-controlled study oftwo successive monthly
of oral metronidazole (400 mg bd for days) in pregnant at 24,weeks’
gestation, with intermediate flora (heavy growth of G. vaginalis) bacterial vaginosis (by
Gram statn). Follow-up vaginal swabs were performed at 28, 32 and 36 weeks’ gestation.
Exclusions included with age <17 years, multiple pregnancy, recent antibiotics for
vaginal discharge
Results 625 fully completed the study protocol at ofthe participating centres.
17(5 5%) of 312 in the placebo group gave birth preterm (<37 weeks), compared with
16(5 1%) of 313 in the metronidazole group A direct indicative ofBV present in
341 women, however the PTB rate similar in both the placebo (10/165)and metronidazole
(10/176) groups. In contrast, treatment with metronidazole in with
obstetric/demographic risk factors for PTB, resulted in reduction ofthe PTB rate. Among
with previous preterm dehvery (PPTD), 5(38.5%) of 13 given placebo gave birth
preterm, compared with one(7 7%) of 13 given metronidazole Other categories showing
reducuons in PTB rate "single" [10% placebo 6.2% metronidazole]" "age 20
years" 11.4% 0%]. and "unemployed" [9.7% 3.9%], although these differences
not statistically significant
Conclusions: In at low risk of PTB, treatment ofBV in pregnancy appears to result in
httle reducUon in the PTB rate, (although the power of this negative conclusion is limited
due to sample size). In with risk factors (especially PPTD), treatment ofBV
orgarusms during pregnancy may reduce the PTB rate, however further enrolments
necessary to demonstrate statistically significant reduction
,’ERVICAL ANTIBODIES TO HERPES SIMPLEX VIRUS DURING THE
.I-IIRD TRIMESTER OF PREGNANCY. KA Boess MD, DH Watts MD, ZA
trown MD, L Corey MD, and RL Ashley PhD University Of Washington
ledical Center Depts. of Ob/Gyn & Laboratory Medicine Seattle, WA
)BJECTIVE: To examine cervical secretions for anti-HSV IgA and determine
elationship to HSV shedding during the third trimester of pregnancy.
;TUDY DESIGN: HSV-2 seropositive pregnant women had cervical
ecretions collected weekly for anti-HSV IgA from 26-31 weeks’ until
lelivery. Patients collected daily genital specimens for HSV culture and PCR.
rESULTS: Of 9 HSV seropositive women (8 HSV-2 only and HSV-1 and
tSV-2), 5 (56%) women had a history of symptomatic herpes and 4 (44%)
tad no history of genital symptoms. Cervical anti-HSV IgA was detected on.
0 (35.7%) of 84 days sampled. Anti-HSV IgA was detected on significantly
nore days in women without a history of symptomatic genital herpes (21 of
7, 56.8%) than those with a history of genital HSV (9 of 47, 19.1%) (P<.0001,
:isher’s exact test). No anti-HSV IgA was detected beyond 37 weeks’. Anti-
-ISV IgA positive days were more likely to be PCR negative (20 of 82, 24%),
an PCR ]ositive (8 of 82, 10%) (P=.001, McNemar’s test).
|anti-HSV IA + anti-HSV I;A TOTAL
|PCR+ 18 (10%) 6 (7%) 14(17%)
|PCR- /20 (24%) 48 (59%) 68 (83%)
|TOTAL |28 (34%) 54 (66%) 82 (2 without PCR result)
ONCLUSIONS: HSV-2 seropositive women with no history of
mptomatic genital herpes have anti-HSV IgA present in their cervical
cretions more often than women with a history of symptomatic herpes.
lack of antibody detected beyond 37 weeks’ may be secondary to
munosupression associated with advancing gestation. The possible role
cervical IgA in clearing HSV from the genital tract remains to be
termined.
SESSION2
ATP BIOLUMINESCENCE IS AN EFFECTIVE SCREENING TEST FOR
ASYMPTOMATIC BACTERIURIA OF PREGNANCY. R. Phillip Heine, M.D.,
Brad Shumaker, B.S., Robert Moyer, M.D., Harold Wiesenfeld, M.D., C.M.
University of Pittsburgh, Magee-Womens Hospital, Department of Obstetrics,
Gynecology and Reproductive Sciences, Pittsburgh, PA.
OBJECTIVE: ATP bioluminescence has been shown to be sensitive marker
for symptomatic urinary tract infections. The purpose of this study is to determine if
ATP bioluminescence, leukocyte esterase (LE), or nitrate reduction (N) are sensitive
screening tests for asymptomatic bacteriuria (ASB) of pregnancy.
STUDY DESIGN: Urine specimens were collected on 385 patients entering
prenatal care at Magee-Womens Hospital Outpatient Clinic. Standard cultures were
performed using CNA, sheep blood and MacConkey agarose. ASB was defined as
posuve culture with > l0 CFU/ml of significant pathogen. LE and N were tested by
dipstick analysis (Chemstrip LN, Boehringer Mannheim). The presence ofN or LE
greater than trace considered positive. Bacterial ATP detected using
differential bacterial/mammalian cell lysis followed by the addition of luciferin and
luciferace. The resultant light emission was measured in bioluminometer (New
Horizons Diagnostics) with more than 100 relative light units considered positive
DO HERPES SIMPLEX VIRUS CULTURES OF THENEWBORN PREDICT
NEONATAL HERPES? Brigit V. Brock. MD, Zane A. Brown, MD, Stacy Selke,
MA, Lawrence Corey, MD. University of Washington, Seattle,WA 98195.
Objective: Culturing mothers for Herpes Simalex virus (HSV) at the time of
delivery identifies some, but not all of the infants at risk for developing neonatal
herpes. We hypothesized that in addition to maternal cultures, culturing the neonate
in the delivery room would enhance our ability to identify infants at risk for neonatal
HSV.
Study Design: All obstetrical patients without signs or symptoms of herpes had
cervical and vulvar cultures obtained on admission in labor. In addition, HSV
cultures from the oropharynx of the newborn were obtained in the delivery room.
HSV was isolated using diploid fibroblasts by standard technique.
Results: Out of 9,667 total deliveries between 1989 and 1993, 6,338 women and
7,285 neonates had cultures obtained. Fifty-seven women had positive cultures, of
which 7 had HSV isolated from the cervix, 44 from the vulva, and 6 from both sites.
Over 90% of the "missed" maternal cultures were due to women who presented with
vaginal bleeding, advanced cervical dilation, imminent delivery, clinical HSV
symptoms, or admission for repeat cesarean section. Of the 9,667 deliveries, both
maternal and infant cultures were obtained in 5,201. Of these patients, the virologic
concordance was:
lnfan Gultures
Positive HSV Negative HSV
Maternal Cultures
Positive HSV 0 47
Negative HSV 0 5154
In all of the remaining 2084 infants, the HSV cultures were negative.
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During the study period, 4 infants were infected with neonatal HSV. Two of the
infants were culture negative and were born to culture positive mothers. The other
two infected infants were born to culture negative mothers, but did not receive
cultures in the delivery room.
Conclusion: The addition of culturing the infant for HSV at the time of delivery did
not appear to enhance the sensitivity for detecting infants at risk for developing
neonatal HSV.
VAGINAL DEFENSINS AS LESS-INVASIVE MARKERS FOR
SEXUALLY TRANSMITTED DISEASES (STD).
_Harold C. Wiesenfeld, MD, CM, R. Phillip Heine. MD, Alexander Panyutich PhD,
Marijane Krohn, PhD, Richard L. Sweet, MD. Dept. of Obstetracs, Gynecology, and
Reproductive Sciences, Magee-Womens Hospital, Pittsburgh, PA, and University. of
California, Los Angeles.
OBJECTIVES: Less-invasive STD testing
strategies using inexpensive diagnostic
tests are urgently needed. We evaluated
the levels of defensins, neutrophil 3000
granule products, from the distal vagina
as markers for the presence of STD’s. 2500 STUDY DESIGN: Three hundred patients
ttending STD chmc were enrolled.
All pattents were tested for 2000
N. gonorr/zoeae IGC), C. trachomatis
(CT), and T. vagmalis (TV) by PCR
and/or culture. Swabs from the distal
vagina were collected, and defensins 1000
le ets were measured bv an ELISA assay.
ILESL"L.TS. Overall. l31 women were 500 infected v.ith an STD. Thirty four women
ere infec,ed wth GC. 31 w’ith CT. and 0 (1 with TV. Median vaginal defensins levels
are presented in the graph. Levels associated None Any GC CT "IV
wtth each organism were significantly greater
than those in uninfected women (p<0.001).
CONCLUSION: Defensins are elevated in the
distal vagina in women infected with GC, CT,
or TV. The use of vagn’,zl defensins as sensitive markers for the presence of STD’s
may be less-invasive strategy for STD testing. Expensive diagnostic tests may then
be restricted to those women at greatest likelihood of having an STD, as determined by
elevated vaginal defensins levels.
DETECTION OF CHLAMYDIA TRACHOMATIS IN PREGNANT WOMEN BY
POLYMERASE CHAIN REACTION (PCR), CERVICAL lgA ANTIBODIES AND
ANTIGEN ANALYSIS: RELATION TO PREGNANCY OUTCOME. SS Witkin, AM
Bongiovanni, SR Inglis. Depts. of Ob/Gyn, Comell University Medical College, New
York, NY and Jersey City Medical Center, Jersey City, NJ.
Dbjectives: To compare the prevalence of cervical C. trachomati8 in pregnant
detected by PCR, IgA antibodies and and antigen detection and ascertain their relation
to pregnancy outcome.
Study Design: A total of 211 endocervieal samples from 167 women evaluated.
For each sample aliquots tested for C_. t_raehomatis by PCR (Amplieor, Roche
Diagnostics) and for IgA antibodies to C_...trae.homatis by 6 minute assay (Chlamydia
igA Rapid SeroTest, Savyon Diagnostics). A third sample analyzed by the hospital
clinical laboratory for C. tr.a.homatis antigen (Chlamydiazyme, Abbott). Pregnancy
tutcomes obtained. Laboratory results were not available to the clinician prior to
delivery.
Results: C. trachomatis was detected by PCR in 27 (12.8%) samples from 23 (13.8%)
women, antiehlamydial IgA present in 37 (17.5%) samples from 32
(19.2%) while 24 (11.4%) samples from 20 (12.0%) women positive for
t’-hlamydial antigen. Antibody positive, PCR negative samples were retested by
,;eeond antibody test and repeat PCR using samples spiked with C. traeho.matis.
Compared to PCR, the IgA Rapid SeroTest had sensitivity of 96.3% and specificity
3f 93.5%; the antigen assay had sensitivity relative to PCR of 74.1% and specificity
.)f 97.8%. The pregnancy outcomes 86 (52.1%) patients with term labor (TL), 41
24 8%) with preterm labor (PTL) and 38 (23.0%) with premature rupture of
membranes (PROM). The pregnancies of 11 (47.8%) of the 23 PCR positive women
opposed to 30 (21.1%) of 142 PCR negative women ended in PTL (P=0.009). Only
,hose vomen positive in the IgA anUgen assays who also PCR positive had
P’rL. There relation between Chlamydia detection by any assay and PROM.
onclusions: PCR-detectable C... trachomatis in the endocervix of pregnant women
zorrelates with PTL. In settings where PCR is not available the IgA Rapid SeroTest,
which can be performed in 6 minutes vithout any special equipment, is accurate and
ensitive procedure for detection of cervical C__. traehomatis in pregnant
SESSION3
CHANGES IN VAGINAL FLORA, pH, MYELOPEROXIDASE, AND
CERVICAL HIV DETECTION OVER THE MENSTRUAL CYCLE. DH Watts.
MD, SL Hillier, PhD, RC Coombs, MD, S Klebanoff, MD, PhD, MA Krohn, PhD,
L Rabe, MS. University of Washington, Seattle, WA; University of Pittsburgh,
Pittsburgh, PA.
Objective: To evaluate changes in vaginal pH, bacterial flora, and myeloperoxidase
levels and cervical HIV detection over the menstrual cycle, in preparation for studies
of the effects of vaginal microbicides on the genital tract.
Study Design: Women were evaluated twice weekly over the menstrual cycle (total
visits) with vaginal pH, Gram stain, quantitative bacterial and genital mycoplasma
culture, vaginal myeloperoxidase determinations, and if HIV-positive, plasma and
cervical specimens for HIV testing by lymphocyte co-culture and RNA PCR.
Subjects did daily basal body temperature charts and had midluteal phase
progesterone levels to assess ovulation status.
Results: At baseline, of the HIV negative women, 6 had normal flora by Gram
stain and intermediate. Of the HIV positive women, had normal flora, 2
were intermediate, and had bacterial vaginosis. None had GC, Chlamydia, or
active HSV at enrollment. Among women with a normal Gram stain at enrollment,
Lactobacillus concentrations were stable (+ log) over the cycle, facultative
bacteria including Enterococcus, GBS, and E. coli, varied over the cycle and
anaerobic bacteria were increased during menses. Women with bacterial vaginosis
maintained high levels of anaerobic flora throughout the cycle, pH was stable in the
absence of bleeding and correlated with Gram stain score. Myeloperoxidase data are
incomplete, but levels are variable within each subject and have not correlated with
cervical WBC count, pH, Gram stain score or specific flora. Three (43%) of 7 HIV
positive women had HIV detected by culture of the cervix at least once, but only 4
(8.5%) of 48 cultures were positive. Four (57%) of 7 had cervical HIV detected by
RNA PCR, and 25 (47%) of 53 specimens were positive by PCR. Most women were
persistently po;itive or negative by PCR, but one subject had HIV detected
intermittently.
Conclusions: Normal variations in vaginal flora and myeloperoxidase levels must
be taken into account when assessing the effects of vaginal microbicides. HIV RNA
PCR testing appears useful in detecting genital HIV and should be useful for
assessing the effect of vaginal microbicides on HIV detection.
THE MATERNAL-FETALTRANSFER OF 3TC (LAMIVUDINE) IN THE EX VIVO
HUMAN PLACENTA. Kery_n M. Dias. M.D,, Steven L. Bloom, M.D., Roger E.
Bawdon, Ph.D., Dept. Ob/Gyn, Univ. TX Southwestern Med. Ctr., Dallas, TX
OBJECTIVE: 3TC (lamivudine) is currently being used as treatment for
hepatitis B and in combination therapies for HIV. We sought to study the
transfer of 3TC ((-)-2’-deoxy-3’-thiacytidine) across the human placenta both
alone and in the presence of AZT (zidovudine).
STUDY DESIGN: Nine placentas from term, elective repeat cesarean deliveries
were analyzed using the ex vivo single cotyledon perfusion system. Antipyrine
was utilized as the reference compound for the determination of the clearance
indices of 3TC alone and in combination with AZT. 3TC and AZT
concentrations in the perfusates and tissues were quantified by reverse phase
HPLC.
RESULTS: The clearance index of 3TC at a maternal concentration of 1.39
/g/ml. was 0.23 _+ 0.14. At a peak concentration of 14.6/g/mL the CI was
0.14 + 0.06. When the maternal concentration of AZT was #g/mL, the CI
of 3TC at the peak and trough concentrations was 0.18 _+ 0.08 and 0.19 _+
0.10, respectively. When the concentration of AZ’I was 10/g/ml_ the CI of
3TC was 0.15 _+ 0.07 and 0.17 + 0.09, respectively, for the trough and peak
concentrations. In addition, when the perfusion system was closed, there was
little accumulation in the fetal perfusate, and in the intervillous space of the
placental tissue.
CONCLUSION: These data suggest that the CI of 3TC is not altered by the
addition of AZT at its peak and trough concentrations. These data also
suggest that there is little accumulation of 3TC in the fetal circulation and
placental tissue.
A STUDY OF THE PHARMACOKINETICS OF SINGLE DAILY DOSE
GENTAMICIN INWOMENITH POST PARTUM ENDOMETRITIS.
John A. Sunyecz, MD, Harold C. Wiesenfeld MDCM, R. Phillip Heine, MD.
Department of Obstetrics, Gynecology and Reproductive Sciences, Magee-Womens
Hospital, 300 Halket Street, Pittsburgh, PA 15213
Objectives: Single daily dose therapy has become popular method of
administering aminoglycosides in the non-pregnant patient, due to improved efficacy,
decreased toxicity, and lower cost. We investigated the phannacokinetics of once
daily dose gentamicin in women with post partum endomyometritis.
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Study Design: We studied ten women diagnosed with post partum
endomyometritis. All women received 4.5 mg/kg actual body weight of gentamicin
intravenously once daily as part of their antibiotic regimen. Serum peak and trough
levels were obtained after the first two doses, as well as an eight hour level after the
second dose. Serum creatinine levels were monitored, and ototoxicity was assessed
clinically.
Results: The doses ranged from 255-600 mg (mean=360 rag), and the duration of
therapy was 2-5 days. The mean elimination constant (Ke) was 0.105 (SD +/-
0.008), and the volume of distribution (Vd) was 0.4 l/kg (SD +/- 0.07). The mean
peak levels after the first and second doses were 11.6 tg/ml (SD +/- 2.3) and 13.0
lag/tnl (SD +/- 2.5), respectively. Both trough levels were 0.3 ILtg/ml. The mean
half-life was 6.6 hrs. There was no nephrotoxicity or ototoxicity observed. Clinical
response was seen in 90% of patients; one patient responded with the addition of
hcparin tbr presumed septic pelvic thrombophlebitis.
Conclusions: Once daily dosing of gentamicin results in pharmacokinetic
parameters similar to those observed in non-pregnant patients. No significant drug
accumulation or toxicity occured. Therefore, single daily dose gentamicin in the post
partum patient appears safe to use at 4.5 mg/kg actual body weight. Further studies
necessary to confirm the safety and efficacy demonstrated in this report.
COLONIZATION OF RENAL INTERSTITIAL TISSUE WITH ESCHERICHIA COLI
075:K5:H-BEARING Dr FIMBRIAE: MUTATION IN THE dra OPERON
PREVENTED TUBULOINTERSTITIAL NEPHRITIS. Bogdan Nowicki. M.D.. ph.D. 1,2,
Pawel Goluszko, M.D., Ph.D. 1, Steve Moseley, Ph.D.3, Luan D. Truong, M.D.4, Anil Kaul,
M.D., D.D.S.I, Stella Nowicki, D.D.S.I, Department of Obstetrics and Gynecology, and
Microbiology and Immunology, The University of Texas Medical Branch, Galveston, Texas,
Department of Microbiology and Immunology, Universi,
of Washington, School of
Medicine, Seattle Washington, and Department of Pathology, Renal Pathology Laboratory,
Baylor College of Medicine, Houston, Texas.
D_hjggl_eE. coli that express Dr colonization factors has been recently found in 30% of
pauents with gestational pyelonephritis. In this study, investigated the hypothesis that
renal interstitial binding mediated by the E. coli Dr adhesin in vitro, may be important for the
development of interstitial colonization resulting in tubulointerstitial nephritis in vivo.
Study Design: An insertional dra mutant of clinical E. coli IHI 1128 bearing Dr fimbriae
constructed using suicide vector pGP704. The resulting mutant E. coli IH1128 Dr- lost its
attachment capacity to interstitium. The Dr+ parent strain and Dr- E. coli mutant used to
characterize persistence of infection and associated histological lesions in experimental
model of ascending pyelonephritis.
Results: The Dr+ E. cOli established long term (52 weeks) colonization of renal tissue. In
the Dr- group, 50% of animals cleared infection within 20 weeks and 100% between 32 to 52
weeks, In the Dr+ group, E. coli cells found to colonize the renal interstitium (detected
by hematoxylin-eosin and immuno staining). Fimbrial antigen detected in the
parenchymai regions affected by tubulointerstitial nephritis but not in the non-affected tissue.
Histological changes in the Dr+ group included interstitial inflammation, interstitial fibrosis,
and tubular atrophy in the kidney tissue. In the Dr group, histological lesions
significantly less than those of the Dr group and involved smaller number of
ammais.
Conclusions: The obtained results consistent with the hypothesis that mutation within the
dra region, coding for Dr fimbriae, factor that mediates binding to renal interstitium,
prevents the development of the renal changes characteristically in tubulointerstitial
nephritis. It remains to be investigated whether the gestational pyelonephritis may contribute
to long term complications including hypertension and end stage renal disease. Supported by
NIH Grant R01DK42029 (BN).
FETAL MEMBRANE MICROBIAL FLORA AT TERM: NO ASSOCIATION WITH
CHORIOAMNIONITIS. PAl WSIner-Hansser MD, PhD, Eva Morsing MD, Inga
Htigerstrand MD, PhD, Elisabeth Hoist PhD, Asa Ljung, MD, PhD, Andreas
Herbst MD. Departments of Obstetrics and Gynecology, Pediatrics, Pathology,
and Microbiology, University of Lund, Sweden.
Objectives: To study relationships between microbial flora of fetal membranes,
histopathologic findings of the membranselplacentalumbilical cord, and clinical
symptoms among women delivering at term.
Study Design: We studied consecutive women with singleton pregnancy delivering
at term during a 3-month period. Immediately after delivery of the placenta, the
nurse-midwife separated the fetal membranes. Specimens for culture were
collected between the membranes, close to the placental edge with cotton-tipped
wooden swabs treated with charcoal. The specimens were kept at room
temperature in Stuart’s medium and transported to the laboratory within 24 hours
(within 48 hours during week-ends). Formalin-fixed membrane roles, and placental
and umbilical tissue specimens were studied by a pathologist who was blinded as to
clinical and microbiologic findings.
Results: We obtained culture specimens from the fetal membranes of 312 (96.9%)
of the 330 eligible women who delivered during the study period. At least one
bacterial species was recovered in 218 cases (69.9%). Pathogenic microorganisms
were recovered from 106 (34%) of the 312 membranes. Culture specimens from the
membranes of eight women delivered by elective cesarean section showed no
growth. Sixty-two (35.8%) of the first 173 consecutively delivered women had
histopathologic evidence of chorioamnionitis. We recovered pathogens from the
fetal membranes of 35 (37.2%) women with and 21 (30%) without evidence of
chorioamnionitis in the membranes (O.R.= 1.4, p<0.4). Women with fever during
labor (n=7) were significantly more likely than those not having fever to have
chorioamnionitis (100% vs. 32.1%, O.R.= 16.0).
Conclusions: Growth of pathogens between the fetal membranes after vaginal
delivery do not predict chorioamnionitis.
A I:IANDOMIZED, PROSPECTIVE,THIRD-PARTYBLINDEDSTUDYOF
TIlE EVALUATION0 IPICII:LINISULBACTAMVERSUS
AMYICILLINIGENTA]klICIN INTHETREATMENTOF
CIIORIOAbINIONITES, David Soper, MD. Department fObstetrics and
Gyneenlogy, Medic,a[ College ofVix Rtdunond, Virginia.
Obleca=: To axss theeffi3, and safetyofmnpleillin/sulbaatm (A/S)
zltpared to ampicillhl/getllattli (A/O) In the tt,eatmtmt ofhorioanmionith.
Study design: Patients with chorioamnionitis (temprzature> 100’F on two ooesions,
at least one hour apmtor single temperature 8rearer than 101F and ruptured
membranes and at least one ofthe following; maternal leukoeytosis, mmemal
tachycardia, fetal tahyoat’die, foul smelling anmloti fluid) wore randomly assigned
in double blind fashiont receive either A/S (n 121) A/G (n 120). Clinical
failures were defined as those subjects with persistent temperature elevation (>
100.4"F) for more than 24 hours postpaxtum. Adverse went= tn both subject and
neonatewe assessed.
Results: 155 subjects were evaluable forelliot’. 74/79 (94%) ofsubjects rec,iving
A/S and 73/76 (96%) ofsub reoehrin8 A/G were clinically cured (p NS).
Patients undeqinl; sereau section (8/53) were more likely to fail therapy than
those delivering vaglnally (0/102)[p < 0.001]), more likely to develop postpartum
endnmyometrltis; (5/53v 0/102 [p 0.004]), mad have a longm" hospital duration (5.2
+ 0.7 v,s 3.4 + 0.6 [p < 0.001]), All clinical failures occta’md ha subjects undergoing
e,e,sareml section. Endomyometritls oc,-tm-txl in 3/27 eesareen patieu receiving A/S
atd in 2/26 patients t’teiving A/G (p NS). lqo n’iou= =tdweme evente due
to the study drugs were observed. Minor adver=e events were equally distributed
n the two study groups, lqo neonates died from sepsis.
Condulmm: A/S and A/G are equally etlLive end safe in the of
horiomnnienitt.t Cesamaa section patients are more prone to fall to respond to
anttldotio therapye tothe development ofpostp=tma endomyomeitis.
PATTERNS OF VAGINAL DOUCHING AND THEIR ASSOCIATION
WITH VAGINAL BACTERIOSIS. Bryna Harwood. MD, Robert Mittendorf,
MD, Dr PH, Diane Judge, RN, FNP, Sheela Dayal, MD, Cheryl Walker, MD.
Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL.
Objectives: We studied the behavior of vaginal douching to determine: 1) the
prevalence, methods and rationale for this behavior, and 2) whether douching is
associated with an increased prevalence of vaginal bacteriosis. Study Design:
This is a cross-sectional study of women attending outpatient gynecologic clinics
at the University of Chicago. Structured interviews were administered by trained
female interviewers. Vaginal smears were collected, batched, gram stained, and
analyzed by Nugent’s criteria for vaginal bacteriosis. Results: Of the 103 women
interviewed, 78.6% had douched in their lifetime, and 74.2% of these women
douched at least once a month. Compared with women who did not douche
regularly, women who douched at least once month were more likely to use
genital deodorant products (OR=36.6, 95% CI 4.7-286.4, p<0.001), to report the
belief that douching can eliminate odors (OR=3.5, 95% CI 1.2-9.9, p=0.015), and
to report the belief that douching can prevent vaginal infections (OR=5.3, 95% CI
1.8-16.0, p=0.002). Women who had douched during the past month were more
likely to have vaginal bacteriosis than all other women in the study (OR=4.1,
95%CI 1.0, 16.6, p=0.041). Conclusions: Beliefs about genital hygiene appear
likely to underlie most douching: these include deodorizing and preventing
infection. We found a significant association between recent douching and
vaginal bacteriosis. Any public health efforts designed to discourage douching
will have to consider the complex interplay of cultural and racial differences in
health beliefs and douching behaviors.
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COMPARISON OF CLINICAL MANIFESTATION WITH LAPAROSCOPIC
FINDINGS In ACUTE SALPINGITIS
Eschenbach DA, Wolner-Hanssen P, Hawes SE, Pavletic A, Paavonen J, Holmes
KK. Department of Obstetrics and Gynecology and Medicine, University of
Washington, Seattle
OBJECTIVE: In this report we compared clinical manifestations and tubal
abnormalities observed at laparoscopy among women with acute salpingitis.
STUDY DESIGN: We compared the type, and when applicable, the severity of
clinical manifestations in 82 women with definite laparoscopic evidence of acute
salpingitis. Women with findings other than salpingitis (n=22), normal findings
(n=9) or possible, but not definite salpingitis (n=42) were excluded from these
analyses.
RESULTS: Two general categorie.s of laparoscopic findings were present: 1) tubal
occlusion and moderate to severe adhesions tended to occur together, in 30 patients
and 2) pelvic/abdominal exudate tended to occur separately, in 27 patients. Tubal
occlusion was positively associated with older age, palpable adnexal mass and
negatively associated with rebound tenderness, the tenderness score and the
isolation of Neisseriae gonorrhoeae and Chlamydia trachomatis. Moderate to
severe adhesions were positively associated with duration of abdominal pain and
negatively associated with the tenderness score. Exudate in the pelvis/abdomen
was positively associated with the tenderness score, the white blood count and N.
gonorrhoeae and negatively associated with the duration of pain, oral contraceptive
use and palpable adnexal mass. Reanalyses among patients with no prior history
of PID did not change the findings.
CONCLUSION: Clinical manifestation traditionally used to judge the clinical
severity of PID partially predict the laparoscopic findings, tend to distinguish those
with tubal occlusion and/or moderate to severe adhesion from those with
peritonitis, and provide insight into the pathophysiology. However, the predictive
value of clinical manifestations are low and not reliable for the individual patient.
SESSION4
IDENTIFICATION OF sac-4 MUTATIONS THAT EFFECT
VIRULENCE OF GONOCOCCAL PID STRAINS. Stella Nowicki,
D,D.S,1,2, Prashanth Ram, M.D. 1, Andrzej Skarpetowski, M.D. 1, Tuan Pham 1,2 and
Bogdan Nowicki, M.D., Ph.D. 1,2. Dept. of Ob/Gyn & Microbiology2, The
University of Texas Medical Branch, Galveston, Texas.
Gonococcal PID is most serious and costly complication of gonorrhea.
Pathogenesis of PID is poorly understood. Two major factors contribute to the
virulence of gonococci, 1) resistance to the bactericidal effect of normal human serum
and 2) attachment to human tissues. Clq-mediated virulence is the first significant
difference found between the PID and local strains (Perkin Elmer Award to S.
Nowicki’s laboratory for the best research in STD in 1995). The sac-4 DNA region of
N. gonorrhoeae is known to confer partial serum resistance (serR). We have recently
identified 344 base pair segment in the 3’ end of the sac-4 region which upon
transformation with plasmid pRP350 conferred Clq dependent virulence to laboratory
strain F62 Recently we found two unique local isolates of N. gonorrhoeae which
carried 344 bp fragment but were avirulent in our pup model. We hypothesize that the
344 bp fragment from local strains carry point mutation(s) resulting in abolishing Clq
dependent virulence.
Study design: N. gonorrhoeae strains 1655 and 1653 were used to PCR amplify 344
bp fragments. PCR products were subcloned to appropriate vector. Resultant p.lasmids
pRPI659, pRPI665 were sequenced, and transformed to laboratory strata F62.
Virulence of these constructs was examined on pup model.
Resulls: A 344 bp fragments from local isolates did not confer Clq mediated
virulence to N. gonorrhoeae F62 upon transformation. In control plasmid pRP350
from PID isolate transformed strain F62 to Clq dependent virulent strain. Sequencing
of plasmids pRP1655 and pRPI659 from local strains and pRP350 from PID strain has
been carried out and two deletions and three substitutions were identified. Deletion of
the 5’ segment of pRP350 that overlap identified mutations abolished Clq dependent
virulence.
Conclusions: These results u’e consistent with the hypothesis that mutations in the
344 bp segment of sac-4 may effect virulence of gonococcal isolates.
TIME TO LIVE BIRTH AFTER PELVIC INFLAMMATORY DISEASE
Lisa A, Lcpine, MD, SD Hillis, PhD, PA Marchbanks, PhD,
MR Joeseof, MD, PhD, HB Peterson, MD, A Hadgu, Ph.D, L Westrom, Nil)
OBJECTIVE Our aim was to study the association between severity of pelvic
inflammatory disease (PID) at laparoscopy and the length of time to live birth.
STUDY DESIGN: Beginning in 1960, cohort of 1,730 women in Lund, Sweden
who had clinical symptoms of acute PID and who desired pregnancy was followed
tbr up to 24 years All study participants underwent laparoscopy and were assigned
to of four categories normal findings (n 442), or mild (n 371), moderate
(n 580), or severe (n 337) tubal inflammation Cumulative live birth rates were
obtained by life-table analysis, and proportional hazards ratios were compared
among women with varying degrees of tubal inflammation.
RESULTS. Median time to achieve live birth according to severity of tubal
inflammation at laparoscopic evaluation of PID was 4.0 years for women with no
tubal inflammation, 4 years for women with mild, 6 years tbr women with
moderate, and 11.8 years for women with severe inflammation Three years after
the acute episode of PID, 37% with no inflammation, 38% with mild, 26% with
moderate, and 16% with severe tubal inflammation were successful in achieving
live birth Cumulative proportion of women achieving live birth after 12 or
more years was 90%, 90%, 82%, and 56% respectively, tbr those with no, mild,
moderate, and severe inflammation After adjustment for age and predisposing
factors, women with severe disease and subsequent episodes of PID were eight
times more likely to remain childless as those experiencing single episode with
mild tubal inflammation
CONCLUSIONS Increasing severity of PID correlates with longer time in
achieving live birth These data underscore the importance of PID prevention and
liberal treatment of suspected PID
ANTEPARTUM DRUG ABUSE AND PRETERM DELIVERY OF ALOW BIRTH
WEIGHT INFANT: IS THE RISK ACCOUNTED FOR BY CO-FACTORS?
Marijane A. Krohn, Ph.D., D. Heather Watts, M.D., Sharon L. Hillier, Ph.D.,
David A. Esehenbach, M.D.
Objectives’ The purpose of this study was to determine whether the risk ofpreterm
delivery associated with drug abuse during pregnancy could be accounted for by
charaeterstics ofdrug abusing women such as ethnicity, high number of pregnancies,
increased tobacco use, and high frequency of genital infections.
Study Design: Two cohorts ofwomen were compared for their frequency of preterm
delivery: (I) 181 women seeking treatment for drug abuse (1990-1994) and (2) 557
non-drug abusing women (1984-1986). Both cohorts had evaluations of genital
specimens performed in one laboratory at UWMC. Women participated in personal
interviews and had genital specimens obtained between 16 and 30 weeks gestational
age. At delivery, a structured medi6al record review was conducted and preterm
delivery was defined as gestational age <37 weeks and birth weight <2500 gm.
Results: Drug abusing women were at higher risk of preterm delivery (Unadjusted
Odds Ratio (OR) 3.2, 95% Confidence Interval (CI) 1.7 6.2) Drug abusing
women were also more likely to have the following characteristics: older age, non-
white race, high number of pregnancies, tobacco use, 60% increase in STD’s, and 2.6
fold increase in bacterial vaginosis After multivariable adjustment for competing risks
of preterm delivery, drug abusing women were still at increased risk of preterm
delivery (OR 2.6; 95% CI I. 6.8) When drug abuse (OR 4.2; 95% CI 5-
12) was modelled together with bacterial vaginosis (OR 3.0; 95% CI 1.0-93), it
remained an independent risk for preterm delivery. The risk of preterm delivery
among women with both factors was no greater than the separate risks.
Conclusions: The risk ofpreterm delivery associated with drug abuse during
pregnancy is independent from characteristics ofdrug abusing women: bacterial
vaginosis, STD’s, and demographic and social factors.
PREVALENCE AND CORRELATES OF ANTIBODY TO CHLAMYDIAL
HEAT SHOCK PROTEIN IN WOMEN STD CLINIC ATTENDEES AND
WOMEN WITH CONFIRMED PID
LO Eckert, SE Hawes, P Wolner-Hanssen, CE Stevens, DM Money, RW
Peeling, RC Brunham, KK Holmes, DA Eschenbach, WE Stamm, Department
of Obstetrics and Gynecology and Medicine, University of Washington, Seattle,
National Laboratory for STD CDC and Department of Medicine, University of
Manitoba, Winnipeg
OBJECTIVE: Determine historic, laboratory and laparoscopic factors that
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correlate with antibody to the 60 kD chlamydial heat shock protein (Chsp-60) in
women at risk for chlamydial (CT) cervicitis and acute PID.
STUDY DESIGN: Cross-sectional study of 156 randomly selected STD clinic
attendees without clinical evidence of PID and 150 women with PID confirmed
by laparoscopy (n=69) or endometrial biopsy (n=81). All women underwent a
standard interview, cultures and determinations of antibody to CT using micro-
immunoflorescence and of antibody to Chsp-60 using ELISA. A positive Chsp-
60 level was an optical density (OD) _> 0.2.
RESULTS: Chsp-60 antibody was present in 146 (47%) of the patients. In
multivariate analyses, Chsp-60 antibody was related to confirmed PID
(OR=2.3, CI 1.3-2.4), age > 20 (OR=2.1, CI 1.1-3.8), CT IgG titers of
1:16-1:128 (OR=2.6, CI 1.2-5.7), CT IgG titers > 1:128 (OR=44.7 CI 8.6-
233), > I0 lifetime sexual parters, non-white race and current OC use, but not
to CT culture or IgM titers to CT. Chsp-60 antibody was also related to
laparoscopic findings among those with salpingitis confirmed by laparoscopy.
Chsp <0.2 Chsp 0.2-1.0 Chsp > 1.0 p for trend
(n=30) (n=20), (n=19)
Occluded tubes 3% 50% 42% <0.001
Any adhesions 50% 75% 79% 0.03
Pelvic/abd. pus 83% 75% 53% 0.02
CONCLUSION: Antibody to Chsp-60 appears related to markers of long-
standing infection and upper genital tract pathology, but not acute cervicitis.
Effect of Contracepuve Method on Vaginal Flora. SL Hillier, Ph.D.,TM Hooton,
M.D., Carol Winter, CRNP, W. Stamm, M.D. University of Pittsburgh; Pittsburgh,
PA and University ofWashington, Seattle, WA.
Objective: To evaluate whether use of oral contraceptives (OC), diaphragms (DI),
or cervical caps (CC) alter the vaginal microflora. In vitro data has suggested that
use ofthe spermicide nonoxynol 9 could deplete vaginal lactobacilli.
Study Design: Women attending student health clinic who were changing methods
of birth control were evaluated prior to starting the new method and for the next four
consecutive weeks. Vaginal flora was assessed at each visit, and women recorded
frequency of intercourse and use of the birth control method and nonoxynol 9 by
diary The group was comprised of predominantly by unmarried Caucasian women,
aged 18-30, who were having vaginal intercourse 1-2 times weekly.
Results: 213 women (103 OC, 75 DI, 35 CC) were recruited and followed for one
month, for total of 1065 visits Results for DI and CC use were similar, so the
groups were combined. Within one week of beginning DI or CC use, vaginal
colonization by E. coli increased from 25% (27/111) to 49% (54/110). (P < .05,
McNemar’s test). The increase in E. coli colonization persisted at one .month.
Similarly, use of these barrier methods with nonoxynol 9 increased vaginal
colonization by Enterococcus from 13% at enrollment to 35% one week after using
this new method. However, use of DI and CC did not affect vaginal colonization by
lactobacilli (95% vs. 93%), (3. vaginalis (36% vs. 40%), anaerobic gram negative rods
(40% vs. 55%), Group B streptococci, or yeast. Vaginal colonization by coagulase
negative staphylococci decreased following use of barrier methods for one month
(57% vs. 37%) There was no effect on the vaginal microflora associated with OC
use
Conclusions: Use of diaphragms or cervical caps with nonoxynol 9 increases vaginal
colonization by E. coli and Enterococcus, but has no adverse effect on vaginal
lactobacilli. Use of OC does not alter the vaginal microflora and not increase
colonization by yeast.
Results: Forty-seven women have been randomized.
Variable Azithromycin Erythromycin p*
N=22 N=I8
Compliance 22 (100%) (44.5 %) 0.001
Gastrointestinal side effects (14.3%) 11 (61.1%) <0.001
Positive follow-up cultures 0 (0%) (5.3%) NS
"* X2; data expressed N (%)
Twenty-seven percent of patients treated with erythromycin unable to tolerate the
medication due to gastrointestinal side effects and required to azithromycin. No
patient in the azithromycin group required crossover.
Conclusions: Azithromycin powder is better tolerated and has higher compliance rate than
erythromycin in the treatment of chlamydial cervicitis in pregnancy.
A POPULATION BASED STUDY OF SEXUAL ACTIVITY AMONG 3600 PREGNANTWOMEN
AND ASSOCIATIONS WITH MICROBIOLOGICAL FINDINGS IN THE GENITAL TRACT.
P. Thorsen, N. Ebbesen, P. Jensen, M. Arpi, A. Bremmelgaard, B. Jeune, J. G. Westergaard &
B. R. Meller. Dept. of OblGyn, Odense University Hospital, Denmark.
OBJECTIVE: To evaluate of sexual activity during pregnancy and possible influences of sexual
activity the microbiology of the genital tract.
STUDY DESIGN: Three thousand six hundred pregnant women, attending the Department of
Obstetrics, Odense University Hospital, Denmark, asked to participate in the study. The study
included pelvic examination and samples obtained for Chlamydia trachomatis, genital
mycoplasmas, Trichomonas vagina and aerobe and anaerobic bacteria at enrolment. Further
subjects asked to fill out three questionnaires; at enrolment, at the 30th week of gestation
and at birth. Women who did not complete testing excluded. Sexual activity monitored
by identical detailed questions in each questionnaire. A selected group of pregnant
(n=539) asked to go through addilJonal pelvic examinations during 2nd and 3rd trimester and
at birth.
RESULTS: Two thousand and nine hundred and twenty (81.3%) completed the study.
Mean gestatJonal age at enrolment 17 1/7 weeks. The group with high initial sexual activity
(more than sexual intercourses per week during the prior 4 weeks) decreased gradually from
proportion of 22.9% at inclusion to 7,6% at birth. Test microorganisms found
frequentiy in the group with high sexual activity: Chlamydia trachomatis (3.4% 1.8%; crude OR
1.9, 95% CI 1.1 3.2), Mycoplasma hominis (10.6% 4.1%; crude OR 2.0, 95% CI 1.5 2.7),
Gardnerella vagina (44.7% vs 32.6%; crude OR 1.4, 95% CI 1.2 1.7) and Bacteriodes spp
(7.5% 4.5%; crude OR 1.7, 95% CI 1.2 2.4). Similarly, with than 3 test
m=croorgan=sms (except Lactobaci//us spp.) isolated from the genital tract at inclusion, during 2nd
and 3rd limester and at birth likely to be among the highly sexually active participants
in comparison to the remaining participants (p 0.05).
CONCLUSIONS: 1) Sexual activity decreases 3-fold during pregnancy among with the
most frequent coitus. 2) There is strong association between higher sexual activity and
prevalences of various microorganisms isolated from the genital tract and (3) the number of test
microorganisms isolated.
The type and frequency of intercourse and the number of partners during pregnancy likely play
primary and secondary roles in reproductive tract microecology and risks of infection associated
pregnancy and morbidity.
SESSION5
AZITHROMYCIN POWDER VERSUS ERYTHROMYCIN INTHE TREATMENT OF
CHLAMYDIAL CERVICITIS IN PREGNANCY
Marcus E. Gunter, M.D., C. David Adair, M.D., J.M. Ernest, M.D., Gayle McElroy, PAC,
Dept. of Obstetrics and Gynecology, Bowman Gray School of Medicine, Winston-Salem, NC
Objectives: Determine if single gram dose of azithromycin (Pfizer Labs, New York,
NY) has fewer side effects and better compliance rate than multiple dose regimen of
erythromycin in the treatment of chlamydial cervicitis in pregnancy.
Study Design: There is ongoing randomized clinical trial. All attending their first
and 36 week prenatal visit had cervical swabs taken and analyzed with the Gen-Probe PACE
(Gen-Probe, Inc., San Diego, CA) DNA probe for Chlamydia trachomatis. All patients
with positive results were asked to participate. Patients assigned to receive either one
gram oral dose of azithromycin powder seven days of erythromycin base, 500 mg q.i.d.
Patients unable to tolerate original randomization medications due to gastrointestinal side
effects allowed to crossover to the opposite study medication. Test of cure swabs were
obtained two weeks after completion of treatment. Patients testing positive for Chlamydia
trachomatis at follow-up considered treatment failures and retreated with the other
agent. The incidence of side effects and compliance rates assessed by patient
questionnaire at the two week follow-up visit.
PREVENTION EARLY-ONSET GBS SEPSIS: IMPLEMENTATION OF THE
PROPOSED CDC GUIDELINES
Richard L. Sweet, M.D., Beverly Brozanski, M.D., Faith DiBiasi, B.S., M(ASCP),
Judith Jones B.S.N.
Objectives: The purpose ofthe study was to document the impact ofthe introduction
into clinical practice ofthe proposed CDC guidelines for prevention of early onset
GBS disease.
Study Design: A retrospective study comparing the prevalence of early onset GBS
sepsis (positive blood culture GBS) at Magee-Womens Hospital prior to the institution
ofCDC guidelines (January 1, 1992-June 30, 1995) with the prevalence ofGBS sepsis
following introduction ofthe CDC protocol (October 1, 1995-March 31, 1996). The
microbiology laboratory data base was reviewed for all positive GBS blood cultures
from the nursery, as were the medical records ofblood culture GBS positive
newborns.
Results: From January 1, 1992-June 30, 1995 there were 36 cases of early onset GBS
sepsis among 31,133 births for a rate of 1.15 per 1000 live births. After introduction
ofthe CDC protocol there was case of early onset GBS sepsis in 5500 births or. 18
per 1000 live births (p=0.03). During these time periods the prevalence of maternal
GBS vaginal colonization remained the same (27% vs 25%). By March, 1996
intrapartum prophylaxis for GBS was the most common new antibiotic order
accounting for 36% ofnew antibiotic orders at MWH. Post introduction ofthe CDC
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protocol, IV penicillin made up 83.2% ofthese orders, clindamycin 13.2%,
erythromycin 0.5%, amyicillin 1.3% and other 1.8%.
Conclusions: The proposed CDC guidelines for prevention of early onset GBS
infection in newborns is very effective, reducing early onset GBS 5-fold. Institution
of the CDC protocol was easily accomplished in large community hospital where
two-thirds of deliveries are by private attendings.
DOES THE USE OF AMPICILLIN VERSUS PENICILLIN FOR THE PREVENTION OF
NEONATAL GROUP B STREPTOCOCCAL (GBS) INFECTION RESULT IN HIGHER RATES OF
COLONIZATION WITH RESISTANT ORGANISMS?, Grahnan S, Lezotte D, Merenstem G,
Gibbs R Universt ofColorado, Denver, CO.
Objectives: Both amptclllin and penicillin G recommended for GBS prophylaxis but ampicfllin
may exert selection pressure for resistant organisms. We hypothesize that neonates of pregnant
treated with intrapartum ampicillin will have significantly higher colonizaUon rates with
aerobic gram negative rods (AGNR) compared to neonates of mothers receiving penicillin G.
Study Design: A prospective, randomized, unmasked trial of intrapartum chemoprophylaxis
undertaken. Included at risk for dehvenng infant wth GBS infection per ACOG
gutdehnes. Women randomized by month of admission to receive ampicillin (2g IV followed by
lg every hrs) pemcdlin G (5 million IV every hrs). Prior to initiation of antibiotic treatment,
cultures obtained from the rectum and dstal vagina and placed selective broth media and
Culturette tubes Cultures similarly obtained from the throat, and of the neonates. GBS,
aureus, enterococcus, and AGNR then isolated using standard mcrobiologic techniques. Data
analyzed using Chi-Square and Cochran-Mantel-Haenszel tests.
Results: The treatment groups were not significantly different with respect to maternal age and race,
gestattonal age and the of other antibiotics dunng pregnancy. Overall, there sigmficant
dfference neonatal rates of colonization with 1. AGNR (Amp 19/108 PCN 28/109), 2. GBS
(Amp 1/108 PCN 2/109), 3. Enterococcus (Amp 10/108 PCN 10/109) and 4. S. (Amp
3/108 PCN 4/109) In subgroup analysis of mothers and neonates with paired cultures, the
following differences rates of neonatal colonization noted between the two antibiotic groups:
Maternal Neonatal
+A(;Nrt +ACR mb_mp_ C,iS"
Amplcillln 18 (58%) (29%) (I 6"--’/0) (! i%) (22%)
25 (86%) 13 (45%) (10%) 10 (40%) (38%) (33%)
(n--29)
Rel,tive (vertical with PCN) (10.74) (06-64) (02-85 I)
Conclusions: 1) There higher than expected rate of maternal colonization with -AGNR
2) Amptctlhn did not result selection pressure towards AGNR, ampictihn-resistant AGNR other
orgamsms. 3) There trend toward increased transmission ofAGNR with the of penicillin
We speculate that the selection of resistant organisms may prior to the of intrapartum
chemoprophylaxs and that tntrapartum ampicillin may decrease vertical transmission ofAGNR.
MATERNAL GROUP B STREPTOCOCCAL (GBS) CULTURE STATUS OF
INFANTS GBS POSITIVE AT DELIVERY
Beverly Brozanski, M.D., Marijane A. Krohn, Ph.D., Faith DiBiasi, B.S., M(ASCP),
Judith Jones B.S.N., R.N.C., Sharon L. Hillier, Ph.D., Richard L. Sweet, M.D.
Objectives: The purpose ofthe study was to evaluate maternal determinants of infant
Group B Streptococci colonization at delivery.
Study Design" A cohort of 536 mother/infant pairs were enrolled at Magee-Womens
iHospital from July 1995 to February 1996. Infants had specimens taken before 12 hr
.of life for the isolation ofGBS from the outer ear, throat, anus, and umbilicus.
Specimens were grown on solid media following broth enrichment. Medical records
were reviewed to determine the mother’s antepartum (AP) GBS culture and
intrapartum (IP) chemoprophylaxis status. A subgroup of 216 mothers also had IP
vaginal specimens taken for GBS isolation when they were admitted for delivery.
Results: Maternal GBS colonization rates in the AP and IP were 26% and 24%,
respectively. Seven percent (38/536) of infants were GBS positive from at least one
site. Infants were more likely to be positive if maternal AP cultures had been positive
(12% versus 5%; P=0.02) but 56% of positive infants were born to culture negative
mothers. Infants treated with IP antimicrobials for > 4 hr had 54% reduction in
colonization (95% CI 0.2-1.3) compared to infants whose mothers were untreated or
treated <4 hr AP cultures were 77% sensitive and 82% specific for predicting women
positive at delivery but 23% ofwomen who were positive at delivery were negative
earlier in pregnancy. Women who were positive at any testing time were more likely
to have culture positive infant when compared to those who were negative at both
testing times (19% versus 0.7%; P < 0.0001)
Conclusions: Antepartum maternal specimens taken for the isolation ofGBS are
inadequate predictors ofwhich women will be positive at delivery. Negative
antepartum maternal culture sta,’us may result in false reassurance that the infant is not
at risk for invasive GBS disease.
SECRETORY LEUKOCYTE PROTEASE INHIBITOR (SLPI) IN
VAGINAL SECRETIONS IS DEGRADED BY CYSTEINE
PROTEASES OF TRICHOMONAS VAGINALIS. Deborah Drap.e.r,
Ph.D., William Donohoe, B.S., R. Phillip Heine, M.D. Magee-Womens
Research Institute and University of Pittsburgh, Pittsburgh, PA.
The mechanism of enhancement of acquisition ofHIV infection by co-
infection with sexually transmitted diseases (STDs) is unknown. SLPI, serine
protease inhibitor, is known to protect oral mucosal surfaces from transmission of
the AIDS virus through its inhibition of the protease activity required for HIV
infection of mucosal monocytes and macrophages. However, little is known about
SLPI function in the genital tract. Objective: This study was undertaken to
determine if the abundant, secreted cysteine proteases of T. vaginalis degrade
purified SLPI or SLPI found in vaginal secretions and render it non-functional.
Study Design: Proteases were induced from isolates of T. vaginalis collected
from pregnant patients. Protozoan-free, supernatant proteases were fractionated by
isoelectric point over pH gradient of 3.0 to 9.0 using BioRad RotopHer.
Dialyzed, pH gradient fractions of proteases were mixed with human recombinant
SLPI (2 ug) with freshly collected vaginal secretions from normal women (n=3)
and incubated at 37C for 20 hours. The degradation patterns of the mixtures were
followed by SDS-PAGE and Western immunoblot analysis using SLPI sp.ecific
polyclonal antiserum. Protease inhibitory function of SLPI was tested using serine
protease peptide-specific substrates in the presence or absence of Trichomonas
proteases and excess E-64 inhibitor. Results: Two T. vaginalis proteases (Mr of
32 and 100kDa) with isoelectric points of approximately pH 7.0, completely
degraded the purified SLPI Western signal within 20 hours. These proteases were
also able to degrade endogenous SLPI in vaginal secretions. Cysteine protease
inhibitor, E-64, completely protected recombinant SLPI from degradation or loss
of functional activity. Conclusions: These studies demonstrate that T. vaginalis
cysteine proteases can degrade SLPI in vitro, and could play role in the in vivo
degradation of SLPI, thereby rendering the vaginal immune cells more susceptible
to HIV infection. These findings could explain the increased risk of HIV
acquisition seen in association with T. vaginalis infection and could provide
mechanism for enhancement of HIV infection by other non-ulcerative STDs.
THE EFFECT OF CHLAMYDIA TRACHOMATIS AND INFLAMMATORY
LEUKOCYTES ON HIV-! REPLICATION IN VITRO
Daniel V. Landers, MD, John P. Mills, Jr., BS, MT(ASCP), Faith DiBiasi, BS, M(ASCP),
Julius Schachter, Ph,DL
University of Pittsburgh and Magee-Womens Research Institute and University of
Cahforma, San Franciscok
Objectives: Epidemiological studies have shown that Chlamydia trachomatis (CT)
infection is risk factor for HIV acquisition. Polymorphonuclear ieukocytes (PMNs) and
mononuclear cells (PBMCs)are found in the female genital tract response to CT
infection. We studied the effects of CT extracts and inflammatory leukocytes HIV-I
replication in vitro.
Study Design: Chronically HIV-! infected monocytic cells (U l) incubated with CT
(human E strain) extract, PMNs, PBMCs. HIV replication determined by p24
antigen measurement at 24, 48, 72, and 96 hours.
Results: After 96 hours of incubation HIV replication increased 25 fold with PBMC
coincubation (p<0.01), 48 fold with PMN coincubation (p<0.01), 27 fold with CT extract
and PBMC coincubation (p<0.Ol), and 33 fold with CT extract and PMN coincubation.
Table shows data for 24, 48, 72, and 96 hours:
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CONTROL
Table [] CT
PBMC’S
[] PMN’S
[] PBMC’S CT
PMN’S GT
24h. 48h 72h 96h.
Conclusion: Inflammatory cells found in the female genital tract, in association with CT
infection, significantly enhance HIV replication in vitro. CT alone in combination with
inflammatory cells did not further enhance HIV replication. This data suggests that the
inflammatory response to CT infection is part responsible for increased risk of HIV
acquisition. Further studies needed to elucidate this complex interaction.
VAGINAL INFECTIONS IN HIV
Helott. A_ M.D, Eriksen, N., M.D., Myers, G., CNM, Lorimor, R., Ph.D.,
Blaneo, J., M.D.
Objectives: In some reports, HIV-infected women have an increased incidence of
recurrent vaginal infections. The purpose of this retrospective review was to identify
the rate ofvaginal infection and treatment response in a cohort ofHIV-infected
women in Houston, Texas.
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Study Design: We reviewed medical records of96 HIV-infected women who had 149
visits from July 1994 to March 1996. We recorded rate and type ofvaginal
infections, the therapeutic regimens and immune status of all patients.
Results: The mean (+ S.D.) age for the entire group was 26.3 +/- 7.7 years, and the
ethnic composition was African-American 81.3%, Hispanic 10.4% and Caucasian
8.3%. There were 52 patients with 59 episodes ofvaginal infection.We found
bacterial vaginosis in 35, Candidiasis in 15 and Trichomonis in 9. The overall failure
rate was of 59 (5.1%). The failures all occurred in patients who received oral
therapy (2 with B.V. and with Candida). One therapeutic failure had a CD4 count
of> 500, the other two had CD4 counts < 200. In this study there was no association
between the occurrence ofvaginal infections and immune status (NS). In addition,
there were no associations between CD4 counts and treatment failure (NS).
Conclusion: This preliminary review demonstrates a 5.1% treatment failure rate for
vaginal infections in HIV-positive women. We found no significant association
between treatment failures, therapeutic regimens or immune status.
SESSION6
TNF-A AND IL-6 PRODUCTION IN THE CHOPdOAMNION AT TERM BY
MACROPHAGES OF MATERNAL AND FETAL ORIGIN AS DETERMINED IN
VIVO BY mRNA INSITUHYBRIDIZATION AND IMMUNOHISTOLOGY
T Roos. MD. D Myerson, MD, SL Hillier, PhD,2 G Cadd, PhD, A Gown, MD, G
Firestein, MD,S DA Eschenbach, MD
Dept ofOB/YN, University of Wuerzburg, FRG and University of Washijgton,
Seattle, WA, Dept of Pathology, Fred I-]utchinson Cancer Research Center, and
University of Washington,sSeattle, WA, and Dept of Medicine, University of
Califomia, San Diego, CA
OBJECTIVES: The origin ofmacrophages associated elevated amniotic fluid (AF)
cytokine (CK) levels oftumor necrosis factor-alpha (TNF-a) and interleukin-6 (IL-6)
examined in term pregnancies.
STUDY DESIGN: 33 women undergoing cesarean section had specimens ofAF,
chorioamnion (CA), decidua (D) and placenta (Plac) collected at delivery. AF, CA
and Plac were cultured. AF TNF-a and IL-6 concentrations were determined by
ELISA. Immunohistologic differentiation was performed on all tissues for T- and B-
lymphocytes and macrophages using antibody markers and/or granulocytes (PMN)
identified by morphology. TNF-a ,d IL-6 producing cells were identified by
mRNA in situ hybridization using S labeled probes. Fetal macrophages were
identified by combined in situ immunohistology and hybridization using macrophage
specific antibody HAM56 and a DNA probe for Y-chromatin.
RESULTS: Both AF infection and labor were associated with elevated AF levels of
TNF-a and IL-6. Macrophages and PMN’s were the predominant cell types in the
CA. IL-6 mRNA signal in the decidua was related to labor while IL-6 mRNA signal
within macrophages in the amnion and chorion was related to positive AF and CA
culture. Macrophages in the amnion were related to positive AF culture. Using the
double stain technique, Y-chromatin positive macrophages were present in all 19
pregnancies with male fetus and in none of 14 pregnancies with female fetus
(p<0.001).
CONCLUSIONS: Fetal amnion and chorion macrophages synthesize CK in response
to infection. Most of these macrophages in the amnion and chorion appear to be of
fetal origin.
DETECTION OF TOXOPLASMA GONDH IN AMNIOTIC FLUID BY A
POLYMERASE CHAIN REACTION/ENZYME-LINKED IMMUNOSORBENT
ASSAY (PCR/ELISA). Jeremias, WJ Ledger, and SS Witkin, Dept. of Ob/Gyn,
Cornell University Medical College, New York, NY
Objectives: Maternal exposure to Toxoplasma gondii during pregnancy may result in
congenital infection and serious sequela in the neonatal period or years after birth.
However, there is little consensus about screening during pregnancy, and the tests
used to establish fetal diagnosis of toxoplasmosis complex and time consuming.
Prenatal diagnosis of congenital toxoplasmosis is based ultrasonography, fetal
blood sampling or inoculation of cultured cells or mice with amniotic fluid. Given the
risk associated with fetal-blood sampling and the delay in obtaining definitive results
with conventional parasitologic methods ultrasound, better methods needed.
T. gondii has been diagnosed by PCR but detection of the amplified product by an
ELISA has, to our knowledge, not been reported. ELISA detection has increased
sensitivity other methods.
Study Design: Using human amniotic fluids that had been spiked with T. gondii, we
established parameters for the amplification and detection of fragment of the 35-fold
repetitive B gene.The 115-base pair product, digoxigenin-labeled, was hybridized to
biotinylatcd internal probe and detected by ELISA. The hybridization validated the
specificity of the amplified PCR product. The possible presence of PCR inhibitors in
individual amniotic fluids was evaluated by amplifying a portion of the human beta
actin gene.
Results: ’/ gondii DNA readily detected in amniotic fluids by our PCR/ELISA.
PCR analysis of DNA extracted from various bacteria, yeast, and viruses using the T.
gondii primer pairs did not result in amplification of any crossreacting DNA.
Similarly, amniotic fluids obtained for genetic analysis were uniformly negative for
7: gondii.
Conclusions: The PCR/ELISA will allow for the definitive diagnosis of congenital T.
gondii infection in day. This sviil reduce the incidence of unnecessary pregnancy
terminations based uncertainty of fetal infection as well as allow the prompt
initiation of antibiotic treatment to infected fetuses.
RISK OF HEPATITIS B TRANSMISSION AFTER AMNIOCENTESIS IN CHRONIC
HEPATITIS B CARRIERS. James Alexander. M.D.,Ronald Ramus, M.D.,Greg Jackson,
M.D.,Barbara Sereecley, R.N., George Wendel, M.D. The University of Texas Southwestern
Medical Center at Dallas, Dallas, Texas
Objectives
The risk of transmission of hepatitis B virus (HBV) from amniocentesis in HBV carriers has
not been thoroughly investigated. In report from Taiwan, the risk of perinatal HBV
transmission in HBV carriers not higher after amniocentesis compared to control group
ofHBV carriers. Immtmoprophylaxis failures occured in 10% of infants in both groups. Our
objective to the risk of transmission of HBV in chronic carriers who undergo
anmiocenteses at hospital.
Study Design
This study prospective, longitudinal study, and data collected about who
HBV carriers and underwent amniocentesis. The infants of these followed
in special clinic from birth to year of age. Maternal data examined included HBV
antigen and antibody status, liver function tests (LFTs), and the amniocentesis procedure report.
Pediatric data obtained from clinic records including the neonatal and 12 month HBsAg
and vaccine record.
Results
25 identified. Two of 25 neonates stillborn unrelated to hepatitis, and
infants lost to follow-up, leaving 18 mother-child pairs to evaluate. All 18
chronic HBV carriers at the time of anmiocentesis and delivery. No mother had abnormal
LFTs, and only of 18 positive for HBeAg. 10 amniocentesis for advanced
maternal age, and for abnormal MSAFP screening. None of the amniocenteses
recorded bloody, and the placenta anterior in of 18 procedures. None of the 18 infants
(95% CI:O-18.5%)were positive for HbsAg during the first month of life at 12 months of
age. All infants received HBV vaccine and HBIg immunoprophylaxis.
Conclusion
The risk of transmission of HBV to the fetus after amniocentesis in who HBV
carriers is low. Immunoprophylaxis in these infants successful.
AMNIOTIC FLUID CONCENTRATIONS OF TNF-a VERSUS TGF-[ IN A
RABBIT MODEL OF INFECTION-INDUCED PRETERM BIRTH. K.K.
Leslie. M.D. L. Reznikov, M.D., Ph.D., R. McDuffie, M.D. F. Cominelli,
M.D. L. Melarfi, Ph.D. R. S. Gibbs, M.D. Department of Obstetrics and
Gynecology, the University of Colorado Health Sciences Center and Kaiser
Permanente, Denver, CO; the Department of Gastroenterology, the University of
Virginia School of Medicine, Charlottesville, VA.
Objectives: In the rabbit model of infection-induced preterm labor, as well
as in women with labor associated with inflammation and infection, the expression
of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-0 and
interleukin-1 (IL-1) stimulate prostaglandin synthesis leading to uterine contractions.
On the other hand, endogenous anti-inflammatory proteins such as transforming
growth factor-beta (TGF-) and interleukin-1 receptor antagonist (IL-lra)inhibit
prostaglandin production. We hypothesize that uterine contractility depends upon
delicate balance between stimulatory and inhibitory cytokine-like factors in the
uterine environment; the purpose of this study was to compare the concentration of
TNF-C to the anti-inflammatory factor TGF- in amniotic fluid using the rabbit
model. Study Design: New Zealand white rabbits at approximately 70% gestation
underwent hysteroscopic inoculation of E. coli and were sacrificed at varying times
after bacterial introduction. Amniotic fluid was collected and assayed for protein
levels of TNF-O and TGF- by enzyme-linked immunoassay (ELISA, R&D
Systems, Minneapolis, MN). Results: TNF-C rose from 0.44 pg/ml at time 0 to
2.5 pg/ml by 16 hrs (P_qg.019). TGF- was significantly higher than TNF-C at
time 0 (610 pg/ml versus 0.44 pg/ml, P.f:0.01), and did not change over time.
Conclusions: (1) TNF-cconcentration, as measured by ELISA, rises significantly
with infection. (2) Compared to TNF- TGF- is present at high levels in the
amniotic fluid but does not change with infection. We speculate that rising TNF-c
in the face of unchanging TGF- creates an imbalance between pro- and anti-
inflammatory cytokines which leads to uterine contractions.
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SEROLOGICAL RESPONSE TO THE CHLAMYDIAL 60 kDa HEAT SHOCK
PROTEIN IN WOMEN WITH TUBAL FACTOR INFERTILITY by, B
Statland, M Smith King, D Dozier and Gunter. University of Kansas Medical
Center Kansas City, KS USA
Objective: to study the relationship between serological response to chlamydia160
kDa heat shock protein (hsp 60) and tubal factor infertility (TFI).
Study Design: Twenty three women with TFI and 33 women with male factor
infertility (controls) were studied. TFI was defined as unprotected intercourse for
one year with hydrosalpinx or distal tubal occlusion on hysterosalpingogram or at
laparoscopy. Demographic data was gathered by chart review. Patients’ sera were
tested for antibodies to the hsp 60 using an enzym.e linked immunoabsorbent assay
(ELISA). Stepwise logistic regression was performed on patient’s age, race/ethnicity,
self reported history’ofChlamydia or pelvic inflammatory disease, history ofectopic
pregnancy and status of anti-hsp antibodies with the hsp 60 ELISA.
Results: Eighteen of the 23 women with TFI had positive result on the hsp ELISA
(78.6%). Significant risk factors for TFI were age 35, (odds ratio 2.23, p
0.0086), "non-white" race (OR 2.05, p 0.0001), history of ectopic pregnancy (OR
2.70, p 0.0008) and a positive hsp 60 ELISA (OR 3.26, p < 0.0001).
Conclusions_: A positive serological response to the hsp 60 is strongly correlated to
TFI. The potential value of the hsp ELISA test should be evaluated in a prospective
study of infertile women.
DISTRIBUTION OF ANTIBODIES TO CHLAMYDIA TRACHOMATIS IN
FOLLICULAR FLUID AND SERA OF WOMEN UNDERGOING IN VITRO
FERTILIZATION (IVF). A. Ne.u.er, K.-N. Lam and L. Kiesel. Dept of Ob/Gyn,
University of Tuebingen Women’s Hospital, Tuebingen, Germany
_Objectives: Unsuspected C. trachgmatis infection has been associated with adverse
IVF outcome. The aim of this study was to determine the prevalence and distribution
of antichlamydial antibodies in follicular fluid and of asymptomatic women
undergoing IVF.
_Study Design: Paired sera and follicular fluids (FF) were obtained at the time of
oocyte aspiration from 149 women undergoing IVF. FF free of visible blood
contamination. Samples assayed for IgG and IgA antibodies to C. trachomatis
by two different ELISA assays employing either recombinant Chlamydia-specific
lipopolysaccharide (LPS) fragment the chlamydial major outer membrane protein
(MOMP). All subjects were tested for cervical C. trachomatis by DNA probe; FF
were tested for C_..tr.achomatis by polymerase chain reaction (PCR) and ligase chain
reaction (LCR).
Results: Sera from 90 (60%) subjects positive for antichlamydial IgG utilizing
the LPS assay; 54 (36%) positive for antichlamydial lgG in the MOMP assay.
Similarly, LPS-directed and MOMP-dirccted IgA antibodies in detected in
50 (34%) and 21 (14%) of the subjects, respectively In FF, IgG antibodies to
MOMP were also more prevalent than IgA antiMOMP antibodies (46% vs. 9%).
However, unlike in sera IgA antiLPS antibodies present in FF from 107 (72%)
vomen opposed to only 50 (34%) being IgG antiLPS positive (P<.0001). In 54
women antichlamydial IgA was detectable in FF but not in the corresponding serum.
All cervical and FF samples negative for C. trachomatis by PCR and LCR.
..Conclusions: Similarities in the prevalence of IgG and IgA antibodies to MOMP in
sera and FF suggest that these antibodies enter the FF primarily by transudation from
the circulation. The greatly increased prevalence of lgA antibodies to chlamydial LPS
in FF suggests that localized humoral immune immune response to this antigen may
be induced in the upper genital tract in the absence of systemic tmmune response.
Perhaps differential expression of chlamydial antigens during chronic upper genital
tract infection acute lower tract infection could account for the variability in
antibody specificity.
PROPHYIaCTIC ANTIBIOTICS AND ENDOMETRIAL MICROFLORA.w
ewQn, MD,.,* Dept. Ob/Gyn/Reprod Sciences Univ Texas Med Schl at
Houston, TX.
OBJECTIVE= To determine the effect of prophylactic antibiotics
the endometrial microflora at the diagnosis of post-cesarean
endometritis.
STUDY DESIGN= The records of 691 subjects involved in comparative
trials of therapeutic antibiotics for post-partum endometritis
between 1989-1994 reviewed. Intravenous prophylactic
antibiotics ampicillin (AMP) g q6h 1-3 doses, cefazolin (CEF)
g q6h 1-3 doses other (cefotetan g dose, Unasyn g q6h
1-3 doses). Endometritis diagnosed with post-partum
temperature 38oC recorded twice, hours apart and associated with
localizing signs and symptoms. Endometrial cultures obtained
by sheathed, injection/aspiration technique. Aerobes and
anaerobes isolated by standard microbiologic techniques.
RESULTS: Culture results available 682 patients. 467/691
(68%) had section. 153 received AMP prophylaxis, i01
received CEF, 17 received other and 196 received prophylaxis.
(Table i; *P<0.01 VS None)
ENDO ISOLATE AMP CEF OTHER NONE
Enterococcus 25% 42%* 29% 21%
K.pneumoniae 25%* 7% 12% 8%
Gram neg rods 39%* 25% 24% 21%
Anaerobes 26%* 34% 39%
There significant differences in rate by prophylaxis
group. However, cefazolin and other groups had higher rate of
wound infection
CONCLUSIONS: 1-3 doses of first generation lactam antibiotics
alter genital tract microflora. The of 1-3 doses of ampicillin
for group B streptococcus prophylaxis may have similar consequences.
However, the clinical significance of changes in vaginal flora
poorly elucidated.
PHAGE INFECTION IN VAGINAL LACTOBACILLh AN IN VITRO MODEL. SM
SI Pavlova, PhD; AO Kilic, PhD; and L Tao, PhD. University of
Missouri-Kansas City, Kansas City, MO 64108
Objectives: Studies documenting the harmful effects of phage infection
in dairy lactobacilli are common; however, few studies have been conducted to
determine if phage infections can have similar harmful effects on vaginal
lactobacilli. The objectives of this study were to isolate phages from vaginal
lactobacilli and establish an in vitro model to show that phages released from
one woman’s vaginal strains can infect lactobacilli from other women.
Study Design: Vaginal samples were obtained from 39 reproductive-
aged women (1 Native American, 5 Asians, 6 Blacks, and 27 Caucasians). The
selective Rogosa agar was used to isolate lactobacilli, from which phages were
induced by mitomycin C. Phage virulence was analyzed by cross-infecting
these phages against a range of vaginal lactobacilli.
Results: Of 19 samples from women with vaginal infections, 12 did not
have lactobacilli. From the remaining 7 infection samples and the 20 samples
from healthy women, 40 Lactobaci/lus stains were isolated, from which 6
Lactobacil/us species were identified and 7 phages were isolated. One phage,
kc039, was characterized as follows: plaque morphology, small and clear, 1-2
mm in diameter; burst size, 300/cell; spontaneous induction rate, 10"e/cell; DNA,
double stranded and linear, 41 kb; and shape, a hexagonal head and a non-
contractile tail. This phage attacked in vitro 8 out of 39 vaginal Lactobaci//us
strains from other women. One strain, kc013, was completely lysed by kc039.
Conclusions: Bacteriophages were isolated from human vaginal
lactobacilli for the first time, and an in vitro phage-infection model was
established. Further studies are needed to determine if phage infection in
vaginal lactobacilli occurs in vivo in humans and if it is clinically significant.
(Supported by the Concerned Parents for AIDS Research/AmFAR and
the University of Missouri Research Board.)
SUSCEPTIBILITY TESTING OF VAGINAL YEAST ISOLATES USING A BROTH
MICRODILUTION BIOASSAY
Gunter M.D., D. Dozier B.sc., S. Faro M.D., Ph.d.
Objective: Determine the MIC’s of fluconazole, miconazole, and amphotencin B for
vaginal yeast isolates using Alamar blue colodmetric broth m=croddution.
Study Desifln: The test organisms consisted of 19 clinical isolates and corresponding
ATCC strains. The organisms (C. albicans, T. glabrata, and C. tropicalis) isolated
from the posterior vaginal fomix on Sabouraud dextrose agar, identified by standard
methods and subcultured twice to ensure purity. The broth microdilution was performed
according to the NCCLS standard guidelines with modification for the Alamar colorimetdc
method Stock solutions of antifungals were prepared in RPMI-1640. MICs were read at
24 and 48 hours. The MIC the lowest concentration of anhfungal solution showing
inhibition of growth. Sterility and growth controls were performed.
Results:
Species
C. albicans
T. glabrata
C. tropicalis
Antifungal agent
fluconazole
amphotedcin B
miconazole
fluconazole
amphotedcin B
miconazole
fluconazole
amphotedcin B
miconazole
MIC (mcglml-range)
24 hrs
0.625-0.25
<0.05
1.0-16.0
<0.0313-0.625
<0.050
1.0-2.0
0 125
<0.050
MIC (mcglml)range
48 hrs
0’.25-2.0
0.25-0.50
<0.50-0.098
2.0-64.0
0.125-0.50
0.195-12.5
40-16.0
0.50
0.391
Conclu..s.i..ons: Using this bioassay the MIC’s for fluconazole, amphotencin B and
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miconazole were determined and found to be within the pubhshed NCCLS reference
ranges. One T. glabrata wild type was resistant to fluconazole and miconazole but not to
amphotedcin B. We are currently increasing the number of isolates tested and correlating
these in vitro results to clinical outcome.
Tiballi RN, et al. Use of a Colorimetdc System for Yeast Susceptibility Testing J. Clin.
Microbiol. 33:915-917
PROPHYLACTIC ANTIBIOTICS ARE NOT NECESSARY FOR MANUAL
EXTRACTION OF PLACENTA FOLLOWING VAGINAL DELIVERY.
M, McNamara.D.O., S. Hall, M.D., B. Gonik, M.D. Dept. Ob/Gyn, Wayne
State Univ. Sch. of Med, Detroit, MI.
OBJECTIVE: Retained placenta is a common intrapartum complication
following vaginal delivery which requires manual extraction (ME). Because
of concerns related to bacterial contamination and subsequent infection,
many clinicians administer antibiotic prophylaxis with this procedure. There
are no data to support the need for antibiotic prophylaxis with ME.
STUDY DESIGN: This retrospective study examined 190 patients who
underwent ME following vaginal delivery. Seventy one patients received
prophylactic antibiotics and 119 patients did not. Indications for ME were
prolonged third stage (123), retained products (16), bleeding (14), avulsed
cord (14), and other (23). None of these patients received intrapartum
antibiotics or were suspected of infection during their labor. Indications for
ME, risk factors for infection and concomitant curettage were similar for
both study groups. The decision to administer antibiotic prophylaxis was
based on individual clinician preference. If antibiotics were given, they were
administered from the time of ME up to 48 hours post procedure. Patients
receiving antibiotic prophylaxis were compared to those not receiving
prophylaxis for post partum infectious morbidity.
RESULTS: Three patients in the prophylaxis group developed post partum
endometritis (4.2%). Of these three patients, one also had uterine curettage.
One subject was admitted on post partum day 10 for suspected
endometritis. All three had 24 hours of prophylactic antibiotics. No patient
in the group not receiving antibiotics developed post partum endometritis.
CONCLUSION: These data suggest that ME following vaginal delivery
does not place the patient at an increased risk for post partum endometritis.
Therefore, prophylactic antibiotics are not necessary.
OVER-THE-COUNTER (OTC) AND ALTERNATIVE MEDICINES (AM) IN
THE TREATMENT OF CHRONIC VAGINAL SYMPTOMS. Paul Nyirjesv.
MD, M. Velma Weitz, MSN; M.H. Terry Grody, MD; Bennett Lorber, MD.
Temple University School of Medicine, Philadelphia, PA.
Objectiv To investigate the use of OTCs and AMs in patients with chronic
vaginal symptoms.
Study Desigtt A prospective cohort study of 109 patients referred by their
gynecologists for evaluation of chronic vaginal symptoms. Patients were
interviewed about their use of OTCs and AMs over the preceding year, the
amount of money spent on each, and whether their physicians had been informed
of these treatments.
Results. The age 35 + 9.2 years; 50.9% had finished college.
Symptom duration was 3.4 + 3.5 years. 79 (72.5%) patients had self-treated with
OTCs such as miconazole (75.6% of OTC users), elotrimazole (38.5%), or
Betadine (14.1%). The average estimated expenditure for OTCs was $88 + $139.
42 (38.5%) had used AMs, most frequently acidophilus pills orally (57.1%) or
vaginally (11.9%), yogurt orally (21.4%) or vaginally (19.0%), garlic pills (9.6%)
and acupuncture (4.8%). Estimated expenditure for AMs was $171 + $284. Fewer
physicians (79%) were aware of the use of AMs than of OTCs (96%) (p<0.01).
Although all patients had received at least one prescribed course of
antimycotics for their conditions, the most common diagnoses at initial
presentation vulvovaginal candidiasis (VVC) in 28 (26.7%), vulvar
vestibulitis in 19 (18.1%), irritant dermatitis in 18 (17%), and bacterial vaginosis
in 12 (11.4%). Women who actually had VVC more likely to have used
AMs (RR 1.8, 95%CI 1.12-2.77) than other patients.
Conclusiotts. Women with chronic vaginal symptoms often use OTCs and AMs
which significantly add to health care costs and are unlikely to be of benefit.
A RETROSPECTIVE ANALYSIS OF SEROLOGIC RESPONSE TO THE
TREATMENT OF SYPHILIS DURING PREGNANCY. Henry_ L. Galan, MD,
Juan Montalvo, MD, John Deaver, MD. Dept of Ob/Gyn, U.T. Medical School,
Houston, TX..
OBJECTIVE: Treatment failures for syphilis during pregnancy continue to account
for high incidence of congenital syphilis. The purpose of this study was to assess
the effect of several variables on the serologic response of syphilis following
treatment in pregnancy.
STUDY DESIGN: A five-year chart review identified 95 patients coded with
syphilis at Hermann Hospital. Inclusion criteria: 1) serologically confirmed syphilis
infection index pregnancy, 2) treatment during the index pregnancy, and 3)
completion ofCDC recommended treatment during the index pregnancy. Forty-nine
of 95 patients met the inclusion criteria. Titer responses were evaluated by assessing
individual’s follow-up titers to the pre-treatment titer as single observation
(dependent variable). Observations were compared in dichotomous fashion by
classifying the response as either positive (>4-fold decline) or negative (<4-fold
decline). Independent variables were also dichotomized and included: 1) pregestational
syphilis treated prior to the index pregnancy, 2) gestational age, 3) titer level, 4)
unknown duration, 5) positive response at month, 6) positive response at 2 months,
7) positive response at > months, 8) parity, 9) race. Analysis performed using Chi
Square and Fisher’s Exact tests with p < 0.05 taken as significant.
RESULTS: A positive response was significantly more likely if there was no prior
history of syphilis or if there was high initial RPR titer (> 32). Only 33/54 (61%)
observations at three months or greater had positive response.
CONCLUSION: Our study suggests that an absence of history of syphilis and an
initial high RPR titer are predictive of positive response following recommended
treatment. We speculate that we may be under-treating our pregnant patients infected
with syphilis. Further studies are needed to evaluate the normal serologic response
following syphilis treatment in pregnancy.
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